GASTON-DREYFUS REMI reported 1 transaction at BIONIK LABORATORIES CORP.
Review the transaction codes below to understand the nature of each event.
Filed: 11/27/2019ACC: 0001104659-19-067939
Director10% Owner
Since Jul 2018
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
5K acquired · 5K disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+5K
Price / share
—
Trade value
—
% of position
0.4%
11/25/2019
1.28M→1.28M
Total
Net shares
+5K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/25/2019 | C · Conversion | +5K | — | — | 0.4% | 1.28M | 1.28M |
| Total | +5K | $0.00 | ||||||
Derivative Transactions1
Exchangeable Shares
Indirect
Converts to
Common Stock
22.47K shares
Shares
−5K
Strike price
Held after
17.48K
Exercisable
—
11/25/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Exchangeable Shares Indirect | Common Stock22.47K shares | 11/25/2019 | C · Conversion | −5K | — | 17.48K |